Intracerebroventricular Glial Cell Line-Derived Neurotrophic Factor Improves Motor Function and Supports Nigrostriatal Dopamine Neurons in Bilaterally 6-Hydroxydopamine Lesioned Rats-Reference-Cited by-同舟云学术

Intracerebroventricular Glial Cell Line-Derived Neurotrophic Factor Improves Motor Function and Supports Nigrostriatal Dopamine Neurons in Bilaterally 6-Hydroxydopamine Lesioned Rats

Published:1997-05 Issue:1 Volume:145 Page:104-117
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Bowenkamp Kathryn E.,Lapchak Paul A.,Hoffer Barry J.,Miller Paul J.,Bickford Paula C.

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference44 articles.

1. Degenerative diseases of the nervous system;Adams,1993

2. A quantitative study on the nigro-striatal dopamine neuron system in the rat;Andén;Acta Physiol. Scand.,1996

3. Brain dopamine and the syndromes of Parkinson and Huntington;Bernheimer;J. Neurol. Sci.,1973

4. 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat;Bowenkamp;Exp. Brain Res.,1996

5. Glial cell-line derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons;Bowenkamp;J. Comp. Neurol.,1995

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Viewpoint on Rat Models of Locomotion Abnormalities and Neurobiological Indicators in Parkinson's Disease;CNS & Neurological Disorders - Drug Targets;2024-04

2. Novel therapeutics for diverse neurodegenerative disorders;A Review on Diverse Neurological Disorders;2024

3. Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives;International Journal of Molecular Sciences;2023-02-15

4. Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective;International Journal of Molecular Sciences;2022-11-25

5. Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy;International Journal of Molecular Sciences;2021-10-28